β-Glucan incorporated into a fruit drink effectively lowers serum LDL-cholesterol concentrations

American Journal of Clinical Nutrition

Volumn 83, Issue 3, 2006, Pages 601-605

  Naumann, Elke ^e   Van Rees, Angelina B ^a   Önning, Gunilla ^b   Öste, Rickard ^c   Wydra, Markus ^d   Mensink, Ronald P ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b LUND UNIVERSITY   (Sweden)

^c Ceba AB   (Sweden)

^d Döhler GmbH   (Germany)

^e NONE

Author keywords

Antioxidants; Campesterol; Cholesterol; Healthy subjects; Lathosterol; Sitosterol; Glucan

Indexed keywords

ANTIOXIDANT; BETA GLUCAN; LATHOSTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PHYTOSTEROL; SITOSTEROL; CHOLESTEROL; SITOSTEROL DERIVATIVE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIET; FEMALE; FOOD INTAKE; FRUIT; HUMAN; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MALE; NORMAL HUMAN; ADOLESCENT; BEVERAGE; BLOOD; CHOLESTEROL INTAKE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DIETARY FIBER; DOUBLE BLIND PROCEDURE; DRUG EFFECT; INTESTINE ABSORPTION; METABOLISM; MIDDLE AGED; RANDOMIZED CONTROLLED TRIAL;

AVENA;

ADOLESCENT; ADULT; AGED; ANTIOXIDANTS; BETA-GLUCANS; BEVERAGES; CHOLESTEROL; CHOLESTEROL, DIETARY; CHOLESTEROL, LDL; DIETARY FIBER; DOUBLE-BLIND METHOD; FEMALE; FRUIT; HUMANS; INTESTINAL ABSORPTION; MALE; MIDDLE AGED; SITOSTEROLS;

EID: 33645634224     PISSN: 00029165     EISSN: None     Source Type: Journal    
DOI: 10.1093/ajcn.83.3.601     Document Type: Article

References (24)

1. FDA Talk Paper. FDA allows whole oat foods to make health claim on reducing the risk of heart disease. 21 January 1997. Internet: www.cfsan.fda.gov/~lrd/tpoats.html. Accessed 27 April 2001.
2. Brown L, Rosner B, Willett WW, Sacks FM. Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69:30-42.
3. Leadbetter J, Ball MJ, Mann JI. Effects of increasing quantities of oat bran in hypercholesterolemic people. Am J Clin Nutr 1991;54:841-5.
4. Lovegrove JA, Clohessy A, Milon H, Williams CM. Modest doses of beta-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr 2000;72:49-55.
5. Beer MU, Arrigoni E, Amado R. Effects of oat gum on blood cholesterol levels in healthy young men. Eur J Clin Nutr 1995;49:517-22.
6. Torronen R, Kansanen L, Uusitupa M, et al. Effects of an oat bran concentrate on serum lipids in free-living men with mild to moderate hypercholesterolaemia. Eur J Clin Nutr 1992;46:621-7.
7. Malkki Y, Autio K, Hanninen O, et al. Oat bran concentrates: physical properties of beta-glucan and hypocholesterolemic effects in rats. Cereal Chem 1992;69:647-53.
8. Lia A, Andersson H, Mekki N, Juhel C, Senft M, Lairon D. Postprandial lipemia in relation to sterol and fat excretion in ileostomy subjects given oat-bran and wheat test meals. Am J Clin Nutr 1997;66:357-65.
9. Lia A, Hallmans G, Sandberg AS, Sundberg B, Aman P, Andersson H. Oat beta-glucan increases bile acid excretion and a fiber-rich barley fraction increases cholesterol excretion in ileostomy subjects. Am J Clin Nutr 1995;62:1245-51.
10. Marlett JA, Hosig KB, Vollendorf NW, Shinnick FL, Haack VS, Story JA. Mechanism of serum cholesterol reduction by oat bran. Hepatology 1994;20:1450-7.
11. Uusitupa MI, Miettinen TA, Sarkkinen ES, Ruuskanen E, Kervinen K, Kesaniemi YA. Lathosterol and other non-cholesterol sterols during treatment of hypercholesterolaemia with beta-glucan-rich oat bran. Eur J Clin Nutr 1997;51:607-11.
12. Kerckhoffs DA, Hornstra G, Mensink RP. Cholesterol-lowering effect of beta-glucan from oat bran in mildly hypercholesterolemic subjects may decrease when beta-glucan is incorporated into bread and cookies. Am J Clin Nutr 2003;78:221-7.
13. Johnson IT, Gee JM. Effect of gel-forming gums on the intestinal unstirred layer and sugar transport in vitro. Gut 1981;22:398-403.
14. Centraal begeleidingsorgaan voor de intercollegiale toetsing. Behandeling en preventie van coronaire hartziekten door verlaging van de plasma cholesterolconcentratie. (Treatment and prevention of coronary heart disease by lowering plasma cholesterol concentrations.) Utrecht, Netherlands: Centraal begeleidingsorgaan voor de intercollegiale toetsing, 1998 (in Dutch).
15. Dutch Food Composition Table 2001. The Hague, Netherlands: Stichting NEVO, 2001.
16. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;18:499-502.
17. Plat J, Mensink RP. Effects of diets enriched with two different plant stanol ester mixtures on plasma ubiquinol-10 and fat-soluble antioxidant concentrations. Metabolism 2001;50:520-9.
18. Önning G, Wallmark A, Persson M, Akesson B, Elmstahl S, Oste R. Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann Nutr Metab 1999;43:301-9.
19. Sundberg B, Wood P, Lia A, et al. Mixed-linked beta-glucan from breads of different cereals is partly degraded in the human ileostomy model. Am J Clin Nutr 1996;64:878-85.
20. Frank J, Sundberg B, Kamal-Eldin A, Vessby B, Aman P. Yeast-leavened oat breads with high or low molecular weight beta-glucan do not differ in their effects on blood concentrations of lipids, insulin, or glucose in humans. J Nutr 2004;134:1384-8.
21. Wilson T, Nicolosi R, Delaney B, et al. Reduced and high molecular weight barley beta-glucans decrease plasma total and non-HDL-cholesterol in hypercholesterolemic syrian golden hamsters. J Nutr 2004;134:2617-22.
22. Ripsin CM, Keenan JM, Jacobs DR Jr, et al. Oat products and lipid lowering. A meta-analysis. JAMA 1992;267:3317-25.
23. Andersson M, Ellegard L, Andersson H. Oat bran stimulates bile acid synthesis within 8 h as measured by 7α-hydroxy-4-cholesten-3-one. Am J Clin Nutr 2002;76:1111-6.
24. Kerckhoffs DAJM. Dietary components and cardiovascular risk markers: effects of tocotrienols, beta-glucan and plant stanol esters. Doctoral dissertation. Maastricht University, Maastricht, Netherlands, 2003.